-
1مؤتمر
المؤلفون: Grosicki, Sebastian, Dhakal, Binod, Malek, Ehsan, Creignou, Maria, Jurczak, Wojciech, Broijl, Annemiek, Iversen, Katrine Fladeland, Gregersen, Henrik, Radocha, Jakub, Chen, Jenny, Ogunkanmi, Adeleye, Spencer, Andrew
المصدر: Grosicki , S , Dhakal , B , Malek , E , Creignou , M , Jurczak , W , Broijl , A , Iversen , K F , Gregersen , H , Radocha , J , Chen , J , Ogunkanmi , A & Spencer , A 2023 , ' GEN3014 (HexaBody ® -CD38) versus daratumumab in patients with relapsed/ refractory multiple myeloma: design of randomized head-to-head expansion cohort of phase 1/2 trial ' , Clinical Lymphoma, Myeloma & Leukemia , vol. 2 , no. Suppl. 2 , P-050 , pp. S62-S63 . < http://10.1016/S2152-2650Test(23)01668-3 >
الإتاحة: https://doi.org/10.1016/S2152-2650Test(23)01668-3
https://vbn.aau.dk/da/publications/0c6b957f-c8af-4cd3-b460-416bfb83d6c9Test -
2مؤتمر
المؤلفون: Spencer, Andrew, Iversen, Katrine Fladeland, Dhakal, Binod, Creignou, Maria, Chen, Jenny, Hiemstra, Ida H, Bosgra, Sieto, Badani, Avani, Breij, Esther C. W., Brady, Lauren K., Sasser, A. Kate, Malmberg, Anders, Gregersen, Henrik, Hansson, Markus, Broijl, Annemiek, Mateos, Maria-Victoria, Plesner, Torben
المصدر: Spencer , A , Iversen , K F , Dhakal , B , Creignou , M , Chen , J , Hiemstra , I H , Bosgra , S , Badani , A , Breij , E C W , Brady , L K , Sasser , A K , Malmberg , A , Gregersen , H , Hansson , M , Broijl , A , Mateos , M-V & Plesner , T 2022 , ' Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) ' ....
الإتاحة: https://doi.org/10.1182/blood-2022-159116Test
https://vbn.aau.dk/da/publications/d88f8ee9-5ede-47a7-916e-dd45078c17e3Test